JW Pharmaceutial

[JW NOW] JW makes another breakthrough by penetrating the European TPN market as the first Asian com

JWGrouphaspersistentlyinvestedconsiderableamountsofmoneyandresourcestobuildaglobal-scalemanufacturinginfrastructureoveralongperiodoftimetogrowourpresenceinoverseasmarkets,andsuchefforthascometofruitio

[JW NOW] JW’s Finomel weighs anchor for its first voyage to Europe

JWGroup’sthird-generationtotalparenteralnutrition(TPN)FINOMEL(launchedas“Winuf”inKorea)hasfinishedarigorousqualityverificationprocessinEuropeaftercompletingthedecentralizedprocedures(DCP)intheregionin

JW’s acquisition of Vietnamese Euvipharm zeroes in on the global pharmerging market

JWGroup,aleadingplayerwithdifferentiatedtechnologicalcapabilityintheKoreanpharmaceuticalmarket,hassetouttopenetratetheglobalpharmergingmarketbyacquiringa100equityofaVietnamesepharmaceuticalcompanyEuvi